ConductScience.org, home

Trial · NCT01436175

Results by group81

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Columbia-Suicide Severity Rating Scale (C-SSRS)SPD489 + AntidepressantPositive Suicidal Ideation68participants
Columbia-Suicide Severity Rating Scale (C-SSRS)SPD489 + AntidepressantSuicidal Attempt4participants
Change From Baseline in Systolic Blood Pressure at Week 52SPD489 + AntidepressantBaseline (n = 1559)117.6Standard Deviation 11.13millimeter of mercury(mmHg)
Change From Baseline in Systolic Blood Pressure at Week 52SPD489 + AntidepressantChange at Week 52/ET (n = 1558)2.4Standard Deviation 10.37millimeter of mercury(mmHg)
Change From Baseline in Diastolic Blood Pressure at Week 52SPD489 + AntidepressantBaseline (n = 1559)75.4Standard Deviation 8.15mmHg
Change From Baseline in Diastolic Blood Pressure at Week 52SPD489 + AntidepressantChange at Week 52/ET (n = 1558)1.2Standard Deviation 7.94mmHg
Change From Baseline in Pulse Rate at Week 52SPD489 + AntidepressantBaseline (n = 1559)72.7Standard Deviation 9.90beats per minute(bpm)
Change From Baseline in Pulse Rate at Week 52SPD489 + AntidepressantChange at Week 52/ET (n = 1558)5.2Standard Deviation 10.58beats per minute(bpm)
Change From Baseline in Sheehan Disability Scale (SDS) Total Score at Week 52/ETSPD489 + AntidepressantBaseline (n=1548)12.7Standard Deviation 7.06units on a scale
Change From Baseline in Sheehan Disability Scale (SDS) Total Score at Week 52/ETSPD489 + AntidepressantChange at Week 52/ET (n = 1530)-4.3Standard Deviation 7.77units on a scale
Number of Participants With Improvement on Clinical Global Impressions - Global Improvement (CGI-I)SPD489 + Antidepressant1021participants
Short Form-12 Health Survey Version 2 (SF-12V2)SPD489 + AntidepressantAggregate Physical49.1Standard Deviation 9.67units on a scale
Short Form-12 Health Survey Version 2 (SF-12V2)SPD489 + AntidepressantAggregate Mental42.7Standard Deviation 11.55units on a scale
EuroQoL Group 5-Dimension 5-Level Self Report Questionnaire (EQ-5D-5L): MobilitySPD489 + AntidepressantNo problems in walking about1193participants
EuroQoL Group 5-Dimension 5-Level Self Report Questionnaire (EQ-5D-5L): MobilitySPD489 + AntidepressantSlight problems in walking about237participants
EuroQoL Group 5-Dimension 5-Level Self Report Questionnaire (EQ-5D-5L): MobilitySPD489 + AntidepressantModerate problems in walking about82participants
EuroQoL Group 5-Dimension 5-Level Self Report Questionnaire (EQ-5D-5L): MobilitySPD489 + AntidepressantSevere problems in walking about24participants
EuroQoL Group 5-Dimension 5-Level Self Report Questionnaire (EQ-5D-5L): MobilitySPD489 + AntidepressantUnable to walk about1participants
EuroQoL Group 5-Dimension 5-Level Self Report Questionnaire (EQ-5D-5L): Self-CareSPD489 + AntidepressantNo problems washing or dressing myself1304participants
EuroQoL Group 5-Dimension 5-Level Self Report Questionnaire (EQ-5D-5L): Self-CareSPD489 + AntidepressantSlight problems washing or dressing myself174participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01436175/results